Clinical Trial

Lateral QL Block vs Intrathecal Morphine for Cesarean Section

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Effective postoperative analgesia after cesarean delivery is essential for maternal recovery, early mobilization, breastfeeding, and maternal-infant bonding. Although intrathecal morphine (ITM) is considered the gold standard for post-cesarean analgesia, its use is associated with opioid-related adverse effects. Ultrasound-guided lateral quadratus lumborum block (QLB-I) has emerged as a promising alternative. This randomized, double-blind, non-inferiority trial aims to compare the postoperative analgesic efficacy of lateral QLB-I with ITM. Secondary outcomes include postoperative opioid consumption, pain scores, opioid-related adverse effects, quality of recovery (ObsQoR-11T), and maternal satisfaction.
Trial Details
NCT Number NCT07712783
Lead Sponsor Ondokuz Mayıs University
Conditions Anesthesia, Postoperative Pain, Regional Anesthesia
Enrollment 56 participants
Start Date 2026-07-15
Primary Completion 2026-09-01 (estimated)
Study Completion 2026-12-01 (estimated)
Updated on ClinicalTrials.gov 2026-07-17